CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine

  1. Cernuda-Morollõn, E.
  2. Martínez-Camblor, P.
  3. Ramõn, C.
  4. Larrosa, D.
  5. Serrano-Pertierra, E.
  6. Pascual, J.
Journal:
Headache

ISSN: 1526-4610,  0017-8748

Year of publication: 2014

Volume: 54

Issue: 6

Pages: 987-995

Type: Article

DOI: 10.1111/HEAD.12372 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus